TR200000475T2 - Stafilokok saraların tedavisi. - Google Patents

Stafilokok saraların tedavisi.

Info

Publication number
TR200000475T2
TR200000475T2 TR2000/00475T TR200000475T TR200000475T2 TR 200000475 T2 TR200000475 T2 TR 200000475T2 TR 2000/00475 T TR2000/00475 T TR 2000/00475T TR 200000475 T TR200000475 T TR 200000475T TR 200000475 T2 TR200000475 T2 TR 200000475T2
Authority
TR
Turkey
Prior art keywords
staphylococcal
epilepsy
treatment
glypeptide
palace
Prior art date
Application number
TR2000/00475T
Other languages
English (en)
Inventor
Ioanna Nicas Thalia
Albert Preston David
Lee Zeckel Michael
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of TR200000475T2 publication Critical patent/TR200000475T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Mevcut bulus, düsük glisopeptit hassasiyetli stafilokok sarasinin neden oldugu enfeksiyonlarin tedavisi ile ilgili tedaviye yöneliktir. Bulus, tercihen, Mu50 türü gibi metisiline karsi dirençli olan stafilokok sara türünden saglanir.
TR2000/00475T 1997-08-22 1998-08-18 Stafilokok saraların tedavisi. TR200000475T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5671297P 1997-08-22 1997-08-22

Publications (1)

Publication Number Publication Date
TR200000475T2 true TR200000475T2 (tr) 2000-08-21

Family

ID=22006150

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00475T TR200000475T2 (tr) 1997-08-22 1998-08-18 Stafilokok saraların tedavisi.

Country Status (23)

Country Link
US (1) US5994297A (tr)
EP (1) EP0897725B1 (tr)
JP (1) JP2001513573A (tr)
KR (1) KR100589548B1 (tr)
CN (1) CN1276728A (tr)
AT (1) ATE278413T1 (tr)
AU (1) AU747418B2 (tr)
BR (1) BR9811917A (tr)
CA (1) CA2301589A1 (tr)
CZ (1) CZ299098B6 (tr)
DE (1) DE69826795T2 (tr)
DK (1) DK0897725T3 (tr)
EA (1) EA002602B1 (tr)
ES (1) ES2229454T3 (tr)
HU (1) HU226593B1 (tr)
ID (1) ID24908A (tr)
IL (2) IL134597A0 (tr)
NO (1) NO327042B1 (tr)
NZ (1) NZ502762A (tr)
PT (1) PT897725E (tr)
TR (1) TR200000475T2 (tr)
UA (1) UA59410C2 (tr)
WO (1) WO1999010006A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2736860C (en) * 2008-08-30 2020-04-28 Targanta Therapeutics Corp. Methods of treatment using single doses of oritavancin
CN101928331B (zh) * 2009-06-26 2014-05-28 上海来益生物药物研究开发中心有限责任公司 一种化合物及其应用
MX2015011760A (es) 2013-03-15 2016-06-10 Melinta Therapeutics Inc Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU703106B2 (en) * 1994-01-28 1999-03-18 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
ATE278413T1 (de) 2004-10-15
EA002602B1 (ru) 2002-06-27
WO1999010006A1 (en) 1999-03-04
EP0897725A2 (en) 1999-02-24
DE69826795T2 (de) 2005-10-06
PT897725E (pt) 2004-12-31
AU8913798A (en) 1999-03-16
EP0897725B1 (en) 2004-10-06
NO20000851L (no) 2000-02-21
NO20000851D0 (no) 2000-02-21
IL134597A (en) 2007-09-20
BR9811917A (pt) 2000-08-15
ES2229454T3 (es) 2005-04-16
ID24908A (id) 2000-08-31
KR20010023108A (ko) 2001-03-26
DE69826795D1 (de) 2004-11-11
CZ299098B6 (cs) 2008-04-23
EA200000250A1 (ru) 2000-08-28
NZ502762A (en) 2001-10-26
HUP0002920A3 (en) 2001-12-28
DK0897725T3 (da) 2004-12-13
KR100589548B1 (ko) 2006-06-15
CA2301589A1 (en) 1999-03-04
AU747418B2 (en) 2002-05-16
US5994297A (en) 1999-11-30
CZ2000619A3 (en) 2001-05-16
HUP0002920A2 (hu) 2001-01-29
HU226593B1 (en) 2009-04-28
NO327042B1 (no) 2009-04-06
JP2001513573A (ja) 2001-09-04
CN1276728A (zh) 2000-12-13
EP0897725A3 (en) 2000-02-09
IL134597A0 (en) 2001-04-30
UA59410C2 (uk) 2003-09-15

Similar Documents

Publication Publication Date Title
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
DE69612003D1 (de) Substituierte benzolaktamverbindungen als substanz-p-antagonisten
DK0986577T3 (da) Opsonisk og beskyttende monoklonale og kimære antistoffer specifikke for lipoteichoicsyre af grampositive bakterier
ATE263157T1 (de) Nematizide trifluorbutene
DE60025632D1 (de) Thrombopoietin-mimetika
MA27549A1 (fr) N-sulfonyl-4-methylene-amino-3-hydroxy-2-pyridones
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
CY1105482T1 (el) Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων
TR200103119T2 (tr) Göz kurumasının tedavisi için madde.
ES2193241T3 (es) Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
ATE310088T1 (de) Behandlung und nachweis von staphylokokkeninfektionen
BR0206697A (pt) Fio tingido espacialmente
PT1383947E (pt) Produtos de fibra bioactivos
ATE199321T1 (de) Anti idiotypische antikörper gegen gonococcen und diese verwendende verfahren und zusammensetzungen.
DK1096952T3 (da) Polysaccharidvaccine mod stafylokok-infektioner
NO980643L (no) Propylendopeptidase inhibitorer
TR200000475T2 (tr) Stafilokok saraların tedavisi.
DE69502223D1 (de) Neue Verwendung von 1Alpha-fluor-25-hydroxy-16-en-23-yn-cholecalciferol
DE69528065D1 (de) Azazyklohexapeptid-verbindungen
FR2812637B1 (fr) Nouveaux composes derives de dihydroporphyrine et leurs applications
TR200003203T2 (tr) Karboksaldehitin saflaştırılması